An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.

Original languageEnglish (US)
Patent numberUS2018125780
IPCA61M 37/ 00 A I
Priority date5/16/16
StatePublished - May 10 2018


Dive into the research topics of 'IMPLANTABLE NANOCHANNEL DELIVERY DEVICES'. Together they form a unique fingerprint.

Cite this